KEDRION BIOPHARMA

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
PRIME POLICY GROUP	—	7

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Commerce, Dept of (DOC)	5
HOUSE OF REPRESENTATIVES	5
U.S. Trade Representative (USTR)	5
SENATE	4
Centers For Medicare and Medicaid Services (CMS)	2
White House Office	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Trade (domestic/foreign)	Trade (domestic/foreign)	7

KEDRION BIOPHARMA — Lobbying Disclosure | Poliscope